Mass General Researchers Uncover Biomarkers That Could Lead to More Patients Getting Immunotherapy
April 18, 2020
April 18, 2020
BOSTON, Massachusetts, April 18 -- Massachusetts General Hospital issued the following news release:
A breakthrough class of cancer treatments - immunotherapies - may become available to a wider range of patients thanks to new research from the Massachusetts General Hospital (MGH).
Microsatellite-high (MSI-H) tumors, which have a high rate of mutations (hypermutant), are more responsive to immunotherapy. Patients with these types of tumors are more likely to be recommen . . .
A breakthrough class of cancer treatments - immunotherapies - may become available to a wider range of patients thanks to new research from the Massachusetts General Hospital (MGH).
Microsatellite-high (MSI-H) tumors, which have a high rate of mutations (hypermutant), are more responsive to immunotherapy. Patients with these types of tumors are more likely to be recommen . . .